Transcriptome sequencing identified novel PRDM10 gene fusions in approximately 5% of undifferentiated pleomorphic sarcomas, characterizing a morphologically low-grade subset without metastases.
Observational (n=84)
PRDM10 fusions are present in around 5% of undifferentiated pleomorphic sarcomas and may define a clinically important, low-grade subset with lower metastatic potential.
PURPOSE: Undifferentiated pleomorphic sarcoma (UPS) is defined as a sarcoma with cellular pleomorphism and no identifiable line of differentiation. It is typically a high-grade lesion with a metastatic rate of about one third. No tumor-specific rearrangement has been identified, and genetic markers that could be used for treatment stratification are lacking. We performed transcriptome sequencing (RNA-Seq) to search for novel gene fusions. EXPERIMENTAL DESIGN: RNA-Seq, FISH, and/or various PCR methodologies were used to search for gene fusions and rearrangements of the PRDM10 gene in 84 soft tissue sarcomas. RESULTS: Using RNA-Seq, two cases of UPS were found to display novel gene fusions, both involving the transcription factor PRDM10 as the 3' partner and either MED12 or CITED2 as the 5' partner gene. Further screening of 82 soft tissue sarcomas for rearrangements of the PRDM10 locus revealed one more UPS with a MED12/PRDM10 fusion. None of these genes has been implicated in neoplasia-associated gene fusions before. CONCLUSIONS: Our results suggest that PRDM10 fusions are present in around 5% of UPS. Although the fusion-positive cases in our series showed the same nuclear pleomorphism and lack of differentiation as other UPS, it is noteworthy that all three were morphologically low grade and that none of the patients developed metastases. Thus, PRDM10 fusion-positive sarcomas may constitute a clinically important subset of UPS.
Hofvander et al. (Tue,) conducted a observational in Undifferentiated Pleomorphic Sarcoma (n=84). Transcriptome sequencing (RNA-Seq), FISH, and PCR was evaluated on Presence of PRDM10 gene fusions. Transcriptome sequencing identified novel PRDM10 gene fusions in approximately 5% of undifferentiated pleomorphic sarcomas, characterizing a morphologically low-grade subset without metastases.